Home > Healthcare > Biotechnology > Biopharma > Cancer Stem Cells Therapy Market

Cancer Stem Cells Therapy Market Trends

  • Report ID: GMI7152
  • Published Date: Oct 2023
  • Report Format: PDF

Cancer Stem Cells Therapy Market Trends

  • The market is experiencing substantial expansion due to several key factors. One of the primary factors is the progressively rising cancer patients globally. For instance, according to the World Cancer Research Fund International, there were an estimated 18.1 million cancer cases globally in 2020.

This surge in cancer incidence has generated a heightened demand for more efficacious treatments. Furthermore, cancer stem cells therapy have been identified as key players in tumor recurrence following initial treatments. Therapies that target these specific cells aim to diminish the likelihood of cancer coming back post-surgery, chemotherapy, or radiation therapy.

  • Conversely, despite the numerous advantages associated with cancer stem cells therapy, a significant challenge and potential obstacle to its widespread adoption. The creation of these therapies necessitates extensive research, preclinical investigations, and clinical trials, all of which not only consume a substantial amount of time but also require significant financial investments.
  • Furthermore, when tailored to target cancer stem cells therapy, these therapies often involve intricate processes such as cell isolation, genetic modification, and personalized treatment planning.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for cancer stem cells therapy was worth USD 4.4 billion in revenue in 2022 and may record USD 12 billion by end of 2032 due to the increasing cases of cancer along with the growing private and public initiatives

The breast type cancer segment accounted for 24.4% of the market share in 2022 propelled by the increased funding and public awareness

North America industry size is expected to grow at 10% CAGR from 2023-2032 owing to presence of exceptionally advanced healthcare infrastructure, featuring state-of-the-art hospitals, research institutions, and biotechnology companies

Gamida Cells, AbbVie Inc, Astellas Pharma Inc, Novadip Biosciences, ReNeuron Group plc, Celyad, Adna GmBH, Thermo Fisher Scientific, Genentech Inc, and Merck KGaA are some of the major cancer stem cells therapy firms

Cancer Stem Cells Therapy Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 256
  • Countries covered: 19
  • Pages: 120
 Download Free Sample